This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Poser, I. Articles by Bosserhoff, A. K. Search for Related Content PubMed PubMed Citation Articles by Poser, I. Articles by Bosserhoff, A. K.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2003, p. 2991-2998, Vol. 23, No. 8
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.8.2991-2998.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Upregulation of HMG1 Leads to Melanoma Inhibitory Activity Expression in Malignant Melanoma Cells and Contributes to Their Malignancy Phenotype

Ina Poser,¹ Michaela Golob,¹ Reinhard Buettner,² and Anja K. Bosserhoff^1*

Institute of Pathology, University of Regensburg, 93053 Regensburg,¹ Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany²

Received 16 August 2002/ Returned for modification 17 September 2002/ Accepted 29 January 2003

Malignant transformation of melanocytes to melanoma cells closely parallels activation of melanoma inhibitory activity (MIA) expression. We have previously shown that upregulation of MIA occurs on a transcriptional level and involves the highly conserved region (HCR) promoter element. We further observed that the HCR element interacts with the melanoma-associated transcription factor (MATF) and thereby confers strong promoter activation. In this study we identify the peptide sequence of MATF and show that it is identical with the transcription factor HMG1. HMG1 was upregulated in malignant melanoma cells and further activated by hypophosphorylation. Stable antisense-HMG1 expression in melanoma cells led to the reduction of MIA promoter activity and protein expression, indicating that HMG1 is a potent regulator of MIA expression. Interestingly, chromatin immunoprecipitation and electrophoretic mobility shift experiments indicated that HMG1 and the NF-B family member p65 both interact and bind to the HCR promoter element. In summary, our study proves HMG1 and p65 to be important factors in MIA regulation and melanoma progression.

---

* Corresponding author. Mailing address: Institute of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. Phone: 49-941-944-6705. Fax: 49-941-944-6602. E-mail: anja.bosserhoff{at}klinik.uni-regensburg.de.

---

Molecular and Cellular Biology, April 2003, p. 2991-2998, Vol. 23, No. 8
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.8.2991-2998.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Gazzar, M. E., Yoza, B. K., Chen, X., Garcia, B. A., Young, N. L., McCall, C. E. (2009). Chromatin-Specific Remodeling by HMGB1 and Linker Histone H1 Silences Proinflammatory Genes during Endotoxin Tolerance. Mol. Cell. Biol. 29: 1959-1971 [Abstract] [Full Text]  
• De Martino, I., Visone, R., Palmieri, D., Cappabianca, P., Chieffi, P., Forzati, F., Barbieri, A., Kruhoffer, M., Lombardi, G., Fusco, A., Fedele, M. (2007). The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. Endocr Relat Cancer 14: 875-886 [Abstract] [Full Text]  
• Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., Lotze, M. T. (2007). Masquerader: High Mobility Group Box-1 and Cancer. Clin. Cancer Res. 13: 2836-2848 [Abstract] [Full Text]  
• Volp, K, Brezniceanu, M-L, Bosser, S, Brabletz, T, Kirchner, T, Gottel, D, Joos, S, Zornig, M (2006). Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55: 234-242 [Abstract] [Full Text]